Influenza vaccine responses in older adults

Acosta-Rodriguez, 2007, Interleukins 1b and 6 but not transforming growth factor-b are essential for the differentiation of interleukin 17-producing human T helper cells, Nat. Immunol., 8, 942, 10.1038/ni1496 Ahmed, 1995, Reduction in mortality associated with influenza vaccine during 1989–90 epidemic, Lancet, 346, 591, 10.1016/S0140-6736(95)91434-X Almanzar, 2005, Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons, J. Virol., 79, 3675, 10.1128/JVI.79.6.3675-3683.2005 Anon., 2009, Update: novel influenza A (H1N1) virus infections—worldwide, May 6, 2009, MMWR, 58, 453 Anon., 2009, Outbreaks of 2009 pandemic influenza A (H1N1) among long-term—care facility residents—three states, MMWR, 59, 74 Anon., 2010, Licensure of a high-dose inactivated influenza vaccine for persons aged > or =65 years (Fluzone High-Dose) and guidance for use—United States, 2010, MMWR, 59, 485 Askonas, 1982, Cytotoxic T-memory cells in virus infection and the specificity of helper T cells, Immunology, 45, 79 Aspinall, 2008, Reversal of age-associated thymic atrophy: treatments, delivery, and side effects, Exp. Gerontol., 43, 700, 10.1016/j.exger.2008.04.014 Aspinall, 2007, Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination, Rejuvenation Res., 10, 5, 10.1089/rej.2006.9098 Atmar, 2009, Adjuvants for pandemic influenza vaccines, Curr. Top. Microbiol. Immunol., 333, 323, 10.1007/978-3-540-92165-3_16 Barker, 1998, A study of the impact of influenza on the functional status of frail older people, Arch. Intern. Med., 158, 645, 10.1001/archinte.158.6.645 Baxter, 2010, Evidence of bias in studies of influenza vaccine effectiveness in elderly patients, J. Infect. Dis., 201, 186, 10.1086/649568 Belshe, 2004, Serum antibody responses after intradermal vaccination against influenza, N. Engl. J. Med., 351, 2286, 10.1056/NEJMoa043555 Benacerraf, 1981, Role of MHC gene products in immune regulation, Science, 212, 1229, 10.1126/science.6165083 Bernstein, 1999, Immune response to influenza vaccination in a large healthy elderly population, Vaccine, 17, 82, 10.1016/S0264-410X(98)00117-0 Boon, 2002, Influenza A virus specific T cell immunity in humans during aging, Virology, 299, 100, 10.1006/viro.2002.1491 Boon, 2010, Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 influenza mouse model, J. Virol., 84, 7662, 10.1128/JVI.02444-09 Butchko, 1978, Specificity studies on the proliferative response of thymus-derived lymphocytes to influenza viruses, J. Immunol., 121, 2381, 10.4049/jimmunol.121.6.2381 Chi, 2010, Immunogenicity and safety of intradermal influenza vaccination in healthy older adults, Clin. Infect. Dis., 50, 1331, 10.1086/652144 Co, 2009, In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses, Vaccine, 27, 319, 10.1016/j.vaccine.2008.09.092 Corti, 2010, Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine, J. Clin. Invest., 120, 1663, 10.1172/JCI41902 Cox, 2004, Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines, Scand. J. Immunol., 59, 1, 10.1111/j.0300-9475.2004.01382.x Czesnikiewicz-Guzik, 2008, T cell subset-specific susceptibility to aging, Clin. Immunol., 127, 107, 10.1016/j.clim.2007.12.002 Darmon, 1995, Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B, Nature, 377, 446, 10.1038/377446a0 de Bruijn, 1997, Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly, Vaccine, 15, 1323, 10.1016/S0264-410X(97)00019-4 de Bruijn, 1999, Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination, J. Infect. Dis., 179, 31, 10.1086/314540 de Bruijn, 2006, The virosomal influenza vaccine Invivac((R)): immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad((R))) in elderly subjects, Vaccine, 24, 6629, 10.1016/j.vaccine.2006.05.035 de Bruijn, 2007, Antibody induction by virosomal. MF59-adjuvanted, or conventional influenza vaccines in the elderly, Vaccine, 26, 119, 10.1016/j.vaccine.2007.10.051 Demotz, 1990, The minimal number of class II MHC-antigen complexes needed for T cell activation, Science, 249, 1028, 10.1126/science.2118680 Dixit, 2007, Ghrelin promotes thymopoiesis during aging, J. Clin. Invest., 117, 2778, 10.1172/JCI30248 Dixit, 2009, Reduction of T cell-derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation, Blood, 113, 5202, 10.1182/blood-2008-09-181255 Effros, 2007, Role of T lymphocyte replicative senescence in vaccine efficacy, Vaccine, 25, 599, 10.1016/j.vaccine.2006.08.032 Effros, 1977, Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses, J. Exp. Med., 145, 557, 10.1084/jem.145.3.557 Effros, 2005, The role of CD8+ T-cell replicative senescence in human aging, Immunol. Rev., 205, 147, 10.1111/j.0105-2896.2005.00259.x Ellebedy, A., Ducatez, M., Duan, S., Stigger-Rosser, E., Rubrum, A., Webb, A., Griffin, Y., DeBeauchamp, J., Webster, R., Govorkova, E., McElhaney, J., Webby, R., submitted for publication. Role of age and seasonal vaccination in protection from pandemic H1N1 2009 influenza virus. Ennis, 1981, HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines, Lancet, 2, 887, 10.1016/S0140-6736(81)91389-1 Ewen, 2003, A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B, J. Immunol. Methods, 276, 89, 10.1016/S0022-1759(03)00073-5 Falsey, 2005, Respiratory syncytial virus infection in elderly and high-risk adults, N. Engl. J. Med., 352, 1749, 10.1056/NEJMoa043951 Falsey, 2009, Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older, J. Infect. Dis., 200, 172, 10.1086/599790 Ferrucci, 1997, Hospital diagnoses Medicare charges, and nursing home admissions in the year when older persons become severely disabled [see comments], JAMA, 277, 728, 10.1001/jama.277.9.728 Fireman, 2009, Influenza vaccination and mortality: differentiating vaccine effects from bias, Am. J. Epidemiol., 170, 650, 10.1093/aje/kwp173 Franceschi, 2000, Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space, Vaccine, 18, 1717, 10.1016/S0264-410X(99)00513-7 Galli, 2009, Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels, Proc. Natl. Acad. Sci. U. S. A., 106, 3877, 10.1073/pnas.0813390106 Gardner, 2002, Age-related changes in Type 1 and Type 2 cytokine production in humans, Biogerontology, 3, 271, 10.1023/A:1020151401826 Gardner, 2001, Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population, Vaccine, 19, 4610, 10.1016/S0264-410X(01)00246-8 Gijzen, 2010, Standardization and validation of assays determining cellular immune responses against influenza, Vaccine, 28, 3416, 10.1016/j.vaccine.2010.02.076 Glezen, 2000, Impact of respiratory virus infections on persons with chronic underlying conditions, JAMA, 283, 499, 10.1001/jama.283.4.499 Goronzy, 2001, Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals, J. Virol., 75, 12182, 10.1128/JVI.75.24.12182-12187.2001 Gorse, 2003, Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study, Vaccine, 21, 2133, 10.1016/S0264-410X(02)00748-X Gorse, 2004, Immunity to influenza in older adults with chronic obstructive pulmonary disease, J. Infect. Dis., 190, 11, 10.1086/421121 Govaert, 1994, The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial, JAMA, 272, 1661, 10.1001/jama.272.21.1661 Govaert, 1994, Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial, Vaccine, 12, 1185, 10.1016/0264-410X(94)90241-0 Hackett, 1990, Virus entry and antigen biosynthesis in the processing and presentation of class-II MHC-restricted T-cell determinants of influenza virus, Immunol. Res., 9, 103, 10.1007/BF02918201 Hackett, 1991, Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation, J. Immunol., 146, 2944, 10.4049/jimmunol.146.9.2944 Hak, 2006, Benefits of influenza vaccine in US elderly—appreciating issues of confounding bias and precision, Int. J. Epidemiol., 35, 800, 10.1093/ije/dyl068 Haynes, 2004, Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo, J. Immunol., 172, 5194, 10.4049/jimmunol.172.9.5194 Holland, 2008, Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial, J. Infect. Dis., 198, 650, 10.1086/590434 Hosaka, 1988, Recognition of noninfectious influenza virus by class I-restricted murine cytotoxic T lymphocytes, J. Immunol., 140, 606, 10.4049/jimmunol.140.2.606 Jackson, 2006, Evidence of bias in estimates of influenza vaccine effectiveness in seniors, Int. J. Epidemiol., 35, 337, 10.1093/ije/dyi274 Jackson, 2006, Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors, Int. J. Epidemiol., 35, 345, 10.1093/ije/dyi275 Jackson, 2008, Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study, Lancet, 372, 398, 10.1016/S0140-6736(08)61160-5 Jansen, 2008, Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program, Vaccine, 26, 5567, 10.1016/j.vaccine.2008.08.003 Jegerlehner, 2004, Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity, J. Immunol., 172, 5598, 10.4049/jimmunol.172.9.5598 Johnson, 2003, Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice, Proc. Natl. Acad. Sci. U. S. A., 100, 2657, 10.1073/pnas.0538056100 Kaech, 2003, Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells, Nat. Immunol., 4, 1191, 10.1038/ni1009 Kang, 2004, Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine, J. Immunol., 173, 673, 10.4049/jimmunol.173.1.673 Keitel, 1988, Efficacy of sequential annual vaccination with inactivated influenza virus vaccine, Am. J. Epidemiol., 127, 353, 10.1093/oxfordjournals.aje.a114809 Khader, 2007, IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge, Nat. Immunol., 8, 369, 10.1038/ni1449 Lamb, 1991, Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus, Proc. Natl. Acad. Sci. U. S. A., 88, 5998, 10.1073/pnas.88.14.5998 Laurence, 2007, TH-17 differentiation: of mice and men, Nat. Immunol., 8, 903, 10.1038/ni0907-903 Lawrence, 2005, Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection, J. Immunol., 174, 5332, 10.4049/jimmunol.174.9.5332 Leng, 2007, Inflammation and frailty in older women, J. Am. Geriatr. Soc., 55, 864, 10.1111/j.1532-5415.2007.01186.x Leroux-Roels, 2009, Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults, Vaccine, 27, 6918, 10.1016/j.vaccine.2009.08.110 Louie, 2009, Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California, JAMA, 302, 1896, 10.1001/jama.2009.1583 Maue, 2009, Proinflammatory adjuvants enhance the cognate helper activity of aged CD4 T cells, J. Immunol., 182, 6129, 10.4049/jimmunol.0804226 McElhaney, 2009, Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response, Expert Rev. Vaccines, 8, 593, 10.1586/erv.09.12 McElhaney, 2009, Immunosenescence: what does it mean to health outcomes in older adults?, Curr. Opin. Immunol., 21, 418, 10.1016/j.coi.2009.05.023 McElhaney, 1996, The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity, J. Immunol. Methods, 190, 11, 10.1016/0022-1759(95)00235-9 McElhaney, 1998, Immune response to influenza vaccination in institutionalized elderly: effect on different T-cell subsets, Vaccine, 16, 403, 10.1016/S0264-410X(97)80918-8 McElhaney, 1998, Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults, Vaccine, 16, 1742, 10.1016/S0264-410X(98)00133-9 McElhaney, 2001, Granzyme B: a marker of risk for influenza in institutionalized older adults, Vaccine, 19, 3744, 10.1016/S0264-410X(01)00087-1 McElhaney, 2006, T cell responses are better correlates of vaccine protection in the elderly, J. Immunol., 176, 6333, 10.4049/jimmunol.176.10.6333 McElhaney, 2009, Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults, Vaccine, 27, 2418, 10.1016/j.vaccine.2009.01.136 McMichael, 1983, Cytotoxic T-cell immunity to influenza, N. Engl. J. Med., 309, 13, 10.1056/NEJM198307073090103 McMichael, 1983, Declining T-cell immunity to influenza, 1977-82, Lancet, 2, 762, 10.1016/S0140-6736(83)92297-3 Min, 2002, Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation, Blood, 99, 4592, 10.1182/blood.V99.12.4592 Min, 2007, Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging, Blood, 109, 2529, 10.1182/blood-2006-08-043794 Mitchell, 1983, Fine specificity of the in vitro antibody response to influenza virus by human blood lymphocytes, J. Immunol., 131, 1229, 10.4049/jimmunol.131.3.1229 Monto, 2009, Influenza control in the 21st century: optimizing protection of older adults, Vaccine, 27, 5043, 10.1016/j.vaccine.2009.06.032 Monto, 2009, Comparative efficacy of inactivated and live attenuated influenza vaccines, N. Engl. J. Med., 361, 1260, 10.1056/NEJMoa0808652 Mosmann, 1986, Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins, J. Immunol., 136, 2348, 10.4049/jimmunol.136.7.2348 Murasko, 2002, Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly, Exp. Gerontol., 37, 427, 10.1016/S0531-5565(01)00210-8 Nelson, 2009, New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors, J. Clin. Epidemiol., 62, 687, 10.1016/j.jclinepi.2008.06.014 Nguyen, 1999, Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues, Virology, 254, 50, 10.1006/viro.1998.9521 Nichol, 2009, Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy, Vaccine, 27, 6305, 10.1016/j.vaccine.2009.07.006 Nichol, 1994, The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community, N. Engl. J. Med., 331, 778, 10.1056/NEJM199409223311206 Nichol, 2003, Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly, N. Engl. J. Med., 348, 1322, 10.1056/NEJMoa025028 Nichol, 2007, Effectiveness of influenza vaccine in the community-dwelling elderly, N. Engl. J. Med., 357, 1373, 10.1056/NEJMoa070844 Okuno, 1993, A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains, J. Virol., 67, 2552, 10.1128/JVI.67.5.2552-2558.1993 Ouyang, 2003, Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1), Exp. Gerontol., 38, 911, 10.1016/S0531-5565(03)00134-7 Ouyang, 2003, Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old, J. Clin. Immunol., 23, 247, 10.1023/A:1024580531705 Palladino, 1991, Activity of CD4+ T-cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitro, J. Virol., 65, 6071, 10.1128/JVI.65.11.6071-6076.1991 Panda, 2010, Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response, J. Immunol., 184, 2518, 10.4049/jimmunol.0901022 Pawelec, 2004, Is immunosenescence infectious?, Trends Immunol., 25, 406, 10.1016/j.it.2004.05.006 Ray, 2004, The collagen binding alpha1beta1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection, Immunity, 20, 167, 10.1016/S1074-7613(04)00021-4 Reichert, 2004, Influenza and the winter increase in mortality in the United States, 1959–1999, Am. J. Epidemiol., 160, 492, 10.1093/aje/kwh227 Renshaw, 2002, Cutting edge: impaired Toll-like receptor expression and function in aging, J. Immunol., 169, 4697, 10.4049/jimmunol.169.9.4697 Rock, 2005, Cross-presentation: underlying mechanisms and role of immune surveillance, Immunol. Rev., 207, 166, 10.1111/j.0105-2896.2005.00301.x Russell, 1979, T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin, Nature, 280, 147, 10.1038/280147a0 Saurwein-Teissl, 2002, Lack of antibody production following immunization in old age: association with CD8(+)CD28(−) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines, J. Immunol., 168, 5893, 10.4049/jimmunol.168.11.5893 Scherle, 1988, Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo, Proc. Natl. Acad. Sci. U. S. A., 85, 4446, 10.1073/pnas.85.12.4446 Simonsen, 2007, Mortality benefits of influenza vaccination in elderly people, an ongoing controversy, Lancet Infect. Dis., 7, 658, 10.1016/S1473-3099(07)70236-0 Simonsen, 2009, Influenza vaccination and mortality benefits: new insights, new opportunities, Vaccine, 27, 6300, 10.1016/j.vaccine.2009.07.008 Skowronski, 2008, Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?, J. Infect. Dis., 197, 490, 10.1086/524146 Stout-Delgado, 2009, Aging promotes neutrophil-induced mortality by augmenting IL-17 production during viral infection, Cell Host Microbe, 6, 446, 10.1016/j.chom.2009.09.011 Sui, 2009, Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses, Nat. Struct. Mol. Biol., 16, 265, 10.1038/nsmb.1566 Sullivan, 2010, Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine, Expert Rev. Vaccines, 9, 1127, 10.1586/erv.10.117 Thomas, 2006, Cell-mediated protection in influenza infection, Emerg. Infect. Dis., 12, 48, 10.3201/eid1201.051237 Thompson, 2003, Mortality associated with influenza and respiratory syncytial virus in the United States, JAMA, 289, 179, 10.1001/jama.289.2.179 Thompson, 2004, Influenza-associated hospitalizations in the United States, JAMA, 292, 1333, 10.1001/jama.292.11.1333 Throsby, 2008, Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells, PLoS One, 3, e3942, 10.1371/journal.pone.0003942 Valenzuela, 2002, Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus, Clin. Immunol., 105, 117, 10.1006/clim.2002.5271 van Duin, 2007, Toll-like receptors in older adults, J. Am. Geriatr. Soc., 55, 1438, 10.1111/j.1532-5415.2007.01300.x Vescovini, 2007, Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects, J. Immunol., 179, 4283, 10.4049/jimmunol.179.6.4283 Voordouw, 2004, Annual revaccination against influenza and mortality risk in community-dwelling elderly persons, JAMA, 292, 2089, 10.1001/jama.292.17.2089 Vu, 2002, A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community, Vaccine, 20, 1831, 10.1016/S0264-410X(02)00041-5